203 related articles for article (PubMed ID: 22057239)
1. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome.
El-Salhy M; Gundersen D; Ostgaard H; Lomholt-Beck B; Hatlebakk JG; Hausken T
Dig Dis Sci; 2012 Apr; 57(4):873-8. PubMed ID: 22057239
[TBL] [Abstract][Full Text] [Related]
2. Endocrine cells in the ileum of patients with irritable bowel syndrome.
El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
World J Gastroenterol; 2014 Mar; 20(9):2383-91. PubMed ID: 24605036
[TBL] [Abstract][Full Text] [Related]
3. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Gilja OH
BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
[TBL] [Abstract][Full Text] [Related]
5. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
El-Salhy M; Vaali K; Dizdar V; Hausken T
Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
[TBL] [Abstract][Full Text] [Related]
6. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).
El-Salhy M; Hatlebakk JG; Hausken T
Neuropeptides; 2020 Feb; 79():101973. PubMed ID: 31727345
[TBL] [Abstract][Full Text] [Related]
7. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
8. Abnormality of peptide YY and pancreatic polypeptide immunoreactive cells in colonic mucosa of patients with colonic inertia.
Zhao RH; Baig KM; Wexner SD; Woodhouse S; Singh JJ; Weiss EG; Nogueras JJ
Dig Dis Sci; 2004; 49(11-12):1786-90. PubMed ID: 15628704
[TBL] [Abstract][Full Text] [Related]
9. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.
El-Salhy M; Hatlebakk JG; Gilja OH; Hausken T
Peptides; 2015 May; 67():12-9. PubMed ID: 25765365
[TBL] [Abstract][Full Text] [Related]
10. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis.
El-Salhy M; Gundersen D; Hatlebakk JG; Hausken T
World J Gastroenterol; 2012 Nov; 18(42):6070-5. PubMed ID: 23155335
[TBL] [Abstract][Full Text] [Related]
11. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.
Simrén M; Stotzer PO; Sjövall H; Abrahamsson H; Björnsson ES
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):55-62. PubMed ID: 12544695
[TBL] [Abstract][Full Text] [Related]
12. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
Scand J Gastroenterol; 2017 Dec; 52(12):1331-1339. PubMed ID: 28853300
[TBL] [Abstract][Full Text] [Related]
13. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study.
Kim HS; Lim JH; Park H; Lee SI
Yonsei Med J; 2010 Jan; 51(1):45-51. PubMed ID: 20046513
[TBL] [Abstract][Full Text] [Related]
14. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
15. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.
Mazzawi T; Hausken T; Gundersen D; El-Salhy M
Eur J Clin Nutr; 2016 Feb; 70(2):175-81. PubMed ID: 26603880
[TBL] [Abstract][Full Text] [Related]
16. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report.
El-Salhy M; Mazzawi T; Gundersen D; Hatlebakk JG; Hausken T
BMC Res Notes; 2013 Sep; 6():391. PubMed ID: 24073715
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
El-Salhy M; Mazzawi T; Gundersen D; Hausken T
Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome: diagnosis and pathogenesis.
El-Salhy M
World J Gastroenterol; 2012 Oct; 18(37):5151-63. PubMed ID: 23066308
[TBL] [Abstract][Full Text] [Related]
19. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
El-Salhy M; Hatlebakk JG; Hausken T
World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
[TBL] [Abstract][Full Text] [Related]
20. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation.
El-Salhy M; Norrgård O; Spinnell S
Scand J Gastroenterol; 1999 Oct; 34(10):1007-11. PubMed ID: 10563671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
